Pharmacokinetic evaluation of the drug interaction between intravenous itraconazole and intravenous tacrolimus or intravenous cyclosporin A in allogeneic hematopoietic stem cell transplant recipients

Biology of Blood and Marrow Transplantation

Volumn 12, Issue 3, 2006, Pages 325-334

  Leather, Helen ^a   Boyette, Renee M ^b   Tian, Lili ^b   Wingard, John R ^b  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Allogeneic hematopoietic stem cell transplantation; Calcineurin inhibitor; Cyclosporin A; Drug interaction; Itraconazole; Pharmacokinetic; Tacrolimus

Indexed keywords

AMPHOTERICIN; AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUDARABINE; ITRACONAZOLE; PHENYTOIN; THYMOCYTE ANTIBODY; TSUKUBAENOLIDE;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BURNING SENSATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DOSE REDUCTION; DRUG MONITORING; DRUG SUBSTITUTION; FEMALE; GRAFT RECIPIENT; HEMATOLOGIC MALIGNANCY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; PRACTICE GUIDELINE; PREDICTION; PROSPECTIVE STUDY; SEIZURE; WHOLE BODY RADIATION;

ADULT; ANTIFUNGAL AGENTS; CYCLOSPORINE; DRUG INTERACTIONS; DRUG MONITORING; FEMALE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAVENOUS; ITRACONAZOLE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TACROLIMUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 33244487685     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2005.10.022     Document Type: Article

References (41)

1. M. Nucci I. Biasoli T. Akiti et al. A double-blind, randomized, placebo-controlled trial of itraconazole capsules as antifungal prophylaxis for neutropenic patients Clin Infect Dis. 30 2000 300-305
2. J.L. Goodman D.J. Winston R.A. Greenfield et al. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation N Engl J Med. 326 1992 845-851
3. F. Menichetti A. Del Favero P. Martino et al. Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: A randomized, placebo-controlled, double-blind trial Clin Infect Dis. 28 1999 250-255
4. G.R. Morgenstern A.G. Prentice H.G. Prentice et al. A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies Br J Haematol. 105 1999 901-911
5. M.A. Slavin B. Osborne R. Adams Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation-a prospective, randomized, double-blind study J Infect Dis. 171 1995 1545-1552
6. K.A. Marr K. Seidel M.A. Slavin et al. Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: A long-term follow-up of a randomized, placebo-controlled trial Blood 96 2000 2055-2061
7. E.J. Bow M. Laverdiere N. Lussier et al. Antifungal prophylaxis for severely neutropenic chemotherapy recipients: A meta analysis of randomized-controlled clinical trials Cancer 94 2002 3230-3246
8. A. Glasmacher A. Prentice M. Gorschluter et al. Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: Evidence from a meta-analysis of 3,597 patients J Clin Oncol. 21 2003 4615-4626
9. C.A. Dykewicz Summary of the guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients Clin Infect Dis. 33 2001 139-144
10. K.A. Marr R.A. Carter F. Crippa A. Wald L. Corey Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients Clin Infect Dis. 34 2002 909-917
11. D.W. Denning J.Y. Lee J.S. Hostetler et al. NIAID mycoses study group multicenter trial of oral itraconazole therapy for invasive aspergillosis Am J Med. 97 1994 135-144
12. D.A. Stevens S.Y. Lee Analysis of compassionate use itraconazole therapy for invasive aspergillosis by the NIAID mycoses study group criteria Arch Intern Med. 157 1997 1857-1862
13. D.W. Denning R.M. Tucker L.H. Hanson D.A. Stevens Treatment of invasive aspergillosis with itraconazole Am J Med. 86 1989 791-800
14. A. Glasmacher C. Hahn E. Molitor T. Sauerbruch G. Marklein G.H. Schmidt-Wolf Definition of an itraconazole target concentration for antifungal prophylaxis Program and Abstracts of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy (Toronto, Ontario, Canada) 2000 American Society of Microbiology Washington, DC 700
15. D.J. Winston R.W. Busuttil Randomized controlled trial of oral itraconazole solution versus intravenous/oral fluconazole for prevention of fungal infections in liver transplant recipients Transplantation 74 2002 688-695
16. K.A. Marr F. Crippa W. Leisenring et al. Itraconazole versus fluconazole for prevention of fungal infections in allogeneic stem cell transplant recipients Blood 103 2004 1527-1533
17. J.T.C. Kwan P.J.D. Foxall D.G.C. Davidson M.R. Bending A.J. Eisinger Interaction of cyclosporin and itraconazole Lancet 2 1987 282
18. M.R. Kramer S.E. Marshall D.W. Denning et al. Cyclosporine and itraconazole interaction in heart and lung transplant recipients Ann Intern Med. 113 1990 327-329
19. M.R. Kramer G. Merin E. Rudis et al. Dose adjustment and cost of itraconazole prophylaxis in lung transplant recipients receiving cyclosporine and tacrolimus (FK 506) Transplant Proc. 29 1997 2657-2659
20. D. Trenk W. Brett E. Jahnchen D. Birnbaum Time course of cyclosporin/ itraconazole interaction Lancet 2 1987 1335-1336
21. D.V. Vlahakos A. Manginas D. Chilidou C. Samanika P.A. Alivizatos Itraconazole-induced rhabdomyolysis and acute renal failure in a heart transplant recipient treated with simvastatin and cyclosporine Transplantation 73 2002 1962-1964
22. J.L. Maxa L.B. Melton C.C. Ogu M.N. Sills A. Limanni Rhabdomyolysis after concomitant use of cyclosporine, simvastatin, gemfibrozil, and itraconazole Ann Pharmacother. 36 2002 820-823
23. S.L. Wimberley M.T. Haug K.M. Shermocj et al. Enhanced cyclosporine-itraconazole interaction with cola in lung transplant recipients Clin Transplant. 15 2001 116-122
24. N.R. Florea B. Capitano C.H. Nightingale et al. Beneficial pharmacokinetic interaction between cyclosporine and itraconazole in renal transplant recipients Transplant Proc. 35 2003 2873-2877
25. T. Ideura T. Muramatsu M. Higuchi N. Tachicana K. Hora K. Kiyosawa Tacrolimus/itraconazole interactions: A case report of ABO-incompatible living-related renal transplantation Nephrol Dial Transplant. 15 2000 1721-1723
26. M. Outeda Macias P. Salvador J.L. Hurtado I. Martin Tacrolimus-itraconazole interaction in a kidney transplant patient Ann Pharmacother. 34 2000 536
27. V. Furlan F. Parquin J.F. Penaud et al. Interaction between tacrolimus and itraconazole in a heart-lung transplant recipient Transplant Proc. 30 1998 187-188
28. M.J. Cervelli G.R. Russ Itraconazole-tacrolimus drug interaction Ther Drug Monit. 25 2003 483-484
29. R. Banerjee N. Leaver H. Lyster N.R. Banner Coadministration of itraconazole and tacrolimus after thoracic organ transplantation Transplant Proc. 33 2001 1600-1602
30. D. Capone A. Gentile P. Imperatore G. Palmiero V. Basile Effects of itraconazole on tacrolimus blood concentrations in a renal transplant recipient Ann Pharmacother. 33 1999 1124-1125
31. C.B. Mahnke R.M. Sutton R. Venkataramanan et. al. Tacrolimus dosage requirements after initiation of azole antifungal therapy in pediatric thoracic organ transplantation Pediatr Transplant. 7 2003 474-478
32. C.L. Osowski S.P. Dix L.S. Lin et. al. Evaluation of the drug interaction between intravenous high-dose fluconazole and cyclosporine or tacrolimus in bone marrow transplant patients Transplantation 61 1996 1268-1272
33. R. Manez M. Martin V. Raman et. al. Fluconazole therapy in transplant recipients receiving FK506 Transplantation 57 1994 1521-1522
34. D.M. Canafax N.M. Graves D.M. Hiilligoss et. al. Interaction between cyclosporin and fluconazole in renal allograft recipients Transplantation 51 1991 1014-1018
35. J.A. Lopez-Gill Fluconazole-cyclosporine interaction: A dose dependent effect? Ann Pharmacother. 27 1993 427-430
36. R. Woestenborghs W. Lorreyne J. Heykants Determination of itraconazole in plasma and animal tissues by high performance liquid chromatography J Chromatogr. 413 1987 332-337
37. K. Venkatakrishnan L.L. von Moltke D.J. Greenblatt Effects of the antifungal agents on oxidative drug metabolism: Clinical relevance Clin Pharmacokinet. 38 2000 111-180
38. R.L. Slaughter D.J. Edwards Recent advances: The cytochrome O450 enzymes Ann Pharmacother. 29 1995 619-624
39. J.M. Poitier G. Cheymol Optimization of itraconazole therapy using target drug concentrations Clin Pharmacokinet. 35 1998 461-473
40. M. Boogaerts D.J. Winston E.J. Bow et. al. Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A randomized, controlled trial Ann Intern Med. 135 2001 412-422
41. D.J. Winston R.T. Maziarz P.H. Chandrasekar et. al. Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial Ann Intern Med. 138 2003 705-713